In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
about
Positron emission tomography imaging of prostate cancerInternational Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease statesBombesin-related peptides and their receptors: recent advances in their role in physiology and disease statesBifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclidesCurrent and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform.Prostate cancer relevant antigens and enzymes for targeted drug deliveryPositron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTAOne-step (18)F labeling of biomolecules using organotrifluoroboratesSynthesis and in vitro and in vivo evaluation of hypoxia-enhanced 111In-bombesin conjugates for prostate cancer imaging.In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe.(18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.Nanopharmacology in translational hematology and oncologyComparative evaluation of three 64Cu-labeled E. coli heat-stable enterotoxin analogues for PET imaging of colorectal cancer.Evolution of bombesin conjugates for targeted PET imaging of tumors.Bombesin receptor-mediated imaging and cytotoxicity: review and current statusIn vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer.Improved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studies.64Cu-labeled phosphonium cations as PET radiotracers for tumor imaging.Estimation of mouse organ locations through registration of a statistical mouse atlas with micro-CT imagesDevelopment of hypoxia enhanced 111In-labeled Bombesin conjugates: design, synthesis, and in vitro evaluation in PC-3 human prostate cancer.[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissuesIn vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer.Molecular imaging of prostate cancer: PET radiotracers.Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant armsEvaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in InsulinomaReceptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotidesEvaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model.Clickable bifunctional radiometal chelates for peptide labelingDesign, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector.A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.Advances in mouse models of prostate cancer.99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor.Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumorsMicrofluidics for synthesis of peptide-based PET tracers.In vitro and in vivo analysis of [(64)Cu-NO2A-8-Aoc-BBN(7-14)NH(2)]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors.68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.Biodistribution and clearance of small molecule hapten chelates for pretargeted radioimmunotherapy.Radiometallated peptides for molecular imaging and targeted therapy.The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.
P2860
Q24596241-514669F4-24F3-4E66-89D4-12D6A31DB831Q24643524-0C18E795-DD64-429C-842D-85B909A77991Q24645097-718288D6-1B6F-4BBF-BEFA-9A8EEA8BAD23Q24649091-D930E788-A3DE-42A4-9FFC-F28655440151Q26746186-99B4B52A-C98F-479F-A043-80A091281107Q27013843-B03F19D3-F6B1-415C-BF54-F7EF48A4E1B3Q28741667-13D3EF4F-4552-46CC-91A5-ACF36E7BC768Q28817698-9BD7F53C-92A5-4445-9F33-A2BD46304EA8Q33725998-BD99E955-09BA-4F8E-B5C9-0864DADA84F9Q33916932-B73905AF-0D0C-4B16-9A97-1440FABD1CB0Q33956262-719F6AFA-9A96-4C45-925F-BDC9A054AF2CQ33961538-73BC6A4D-425B-41BA-8F49-50615B16C726Q34049108-4E49AB34-1300-43E4-811D-00CE156E089AQ34424982-97A6AEE0-4EC4-4FBD-995B-962AA1265283Q34684387-C9AB6300-9474-4B8B-B2F7-88D926752155Q34942281-FAE0D65C-C4ED-4D82-9852-AD1CA4819DB0Q34992753-12CCA414-738D-4EF3-B4B9-0DED0257AFA5Q35169192-D0EC66B4-905D-42A7-AD06-4612137CBBC4Q35702317-43456A30-CCE0-492E-8C01-EA0DB0A98F8AQ35846757-502F8CDA-F127-439A-8881-72E76335A287Q35881049-D3029A8F-84F5-4462-9354-08F5E681D70BQ35925945-9096DC76-BCA2-4069-A1C4-9AC45054CE56Q36129937-D4A99857-55D0-4256-BF11-2131DCBA9FB6Q36291655-4CECBA0F-AF84-4B6D-A0D7-7F452FEF993EQ36383709-59912E93-BD4A-4F27-A165-641C59EA694AQ37015817-51142640-8F43-43D8-8996-715F187F9A09Q37109589-4073A7D6-3C16-43FE-9FF1-1ED5449DFA90Q37120660-A9BF0A59-C0F0-478E-8F35-B4357246FF21Q37137779-C1A30682-8B52-4988-B2CA-C23D10183551Q37172093-D33C358F-6818-4760-B219-D254E32CFD8FQ37185527-0D65EB7D-568A-4F39-A315-91226DCAA960Q37286800-E2C1EC38-3896-4B72-92CE-E47516F56BA5Q37289040-A8EB43B5-41EC-48BA-8755-6E56B4C351E7Q37322485-3C634522-3D6B-42A3-B323-7BF1B4C24142Q37375024-0D462864-63BC-42A9-88F4-EAE9655234C3Q37592067-9B107E0C-571A-4023-B1B2-05BFEB29916EQ37656119-E6B98B94-D5D8-4CED-8B4B-78C8AF5051FDQ37656465-DC7D2081-8F89-4C04-BDB9-D78653064535Q37847064-A7E9A139-409A-4F4A-9F7B-FB5B67EA26B3Q37869905-0EF91B12-B51B-47FB-8D45-AD0470F10B72
P2860
In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
In vivo evaluation and small-a ...... 2A and DOTA chelation systems.
@en
type
label
In vivo evaluation and small-a ...... 2A and DOTA chelation systems.
@en
prefLabel
In vivo evaluation and small-a ...... 2A and DOTA chelation systems.
@en
P2093
P1476
In vivo evaluation and small-a ...... 2A and DOTA chelation systems.
@en
P2093
Gary L Sieckman
Jered C Garrison
Said Daibes Figueroa
Silvia S Jurisson
Tammy L Rold
Timothy J Hoffman
Wynn A Volkert
P304
P356
10.2967/JNUMED.107.039487
P407
P577
2007-07-13T00:00:00Z